诊断学理论与实践 ›› 2016, Vol. 15 ›› Issue (06): 586-594.doi: 10.16150/j.1671-2870.2016.06.009
冯耘, 程挺, 刘嘉琳, 万欢英, 程齐俭
收稿日期:
2016-05-30
出版日期:
2016-12-25
发布日期:
2022-07-27
通讯作者:
程齐俭 E-mail: chengqijian@aliyun.com
基金资助:
FENG Yun, CHENG Ting, LIU Jialin, WAN Huanying, CHENG Qijian
Received:
2016-05-30
Online:
2016-12-25
Published:
2022-07-27
摘要: 目的: 通过分析已有的临床数据,观察多个评估系统对社区获得性肺炎(community acquired pneumonia,CAP)患者30 d的死亡风险和ICU入住风险的预测价值。方法: 用关键词途径对2004年至2015年的PubMed和EMBASE数据库进行文献检索,并对符合条件的所有研究进行荟萃分析。结果: 共纳入文献48篇,共51 639例CAP患者采用各评价系统对其30 d死亡风险进行评估,共评估了10 590例CAP患者入住ICU的风险。通过汇总计算得出,对于30 d死亡风险的预测,CRB-65(confusion,respiratory,age 65 years)评分系统的灵敏度为98%,特异度为33%,综合受试者工作特征(summary receiver operating characteristic,sROC)曲线下面积为0.56;英国胸科协会改良肺炎评分(confusion, uremia, respiratory,blood pressure, age 65 years, CURB-65评分)系统的灵敏度为84%,特异度为55%,sROC曲线下面积为0.78;肺炎严重度指数(pneumonia severity index, PSI)系统的灵敏度为90%,特异度为57%,sROC曲线下面积为0.88;以符合2007美国感染病学会(Infectious Diseases Society of America,IDSA) /美国胸科学会(American Thoracic Society, ATS) 3项以上次要标准且不符合主要标准的评估灵敏度为76%,特异度为90%,sROC曲线下面积为0.89;采用SMART-COP评估的灵敏度为77%,特异度为65%,sROC曲线下面积为0.67。对于入住ICU风险,采用CURB-65系统评估的灵敏度为52%,特异度为77%,sROC曲线下面积为0.67;采用PSI系统评估的灵敏度为70%,特异度为61%,sROC曲线下面积为0.69;采用SMART-COP评分评估的 灵敏度为84%,特异度为70%,sROC曲线下面积为0.74。结论: PSI、CURB-65评分系统对患者30 d死亡风险的预测价值较大,可作为住院标准的重要参考。对于收住ICU的风险评估,SMART-COP的预测价值相对较大,而PSI、CURB-65评分价值相对较低。
中图分类号:
冯耘, 程挺, 刘嘉琳, 万欢英, 程齐俭. 多个评估系统对社区获得性肺炎严重度评估的荟萃分析[J]. 诊断学理论与实践, 2016, 15(06): 586-594.
FENG Yun, CHENG Ting, LIU Jialin, WAN Huanying, CHENG Qijian. Validation and meta-analysis of various severity scale system for predicting mortality and ICU admission in community-acquired pneumonia patients[J]. Journal of Diagnostics Concepts & Practice, 2016, 15(06): 586-594.
[1] Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update2009[J]. Thorax,2009,64 Suppl 3:iii1-55. [2] Leeper KV Jr.Severe community-acquired pneumonia[J]. Semin Respir Infect,1996,11(2):96-108. [3] Bauer TT, Ewig S, Marre R, et al.CRB-65 predicts death from community-acquired pneumonia[J]. J Intern Med,2006, 260:93-101. [4] Capelastegui A, España PP, Quintana JM, et al.Validation of a predictive rule for the management of community-acquired pneumonia[J]. Eur Respir J,2006,27(1):151-157. [5] Barlow G, Nathwani D, Davey P.The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia[J]. Thorax,2007,62(3):253-259. [6] Man SY, Lee N, Ip M, et al.Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong[J]. Thorax,2007, 62(4):348-353. [7] Zuberi FF, Khan JA.Prospective comparison of prediction rules of mortality risk for CAP in a developing country[J]. Int J Tuberc Lung Dis,2008,12(4):447-452. [8] Schuetz P, Koller M, Christ-Crain M, et al.Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings[J]. Epidemiol Infect,2008,136(12):1628-1637. [9] Menéndez R, Martínez R, Reyes S, et al.Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia[J]. Thorax,2009,64(7):587-591. [10] Karmakar G, Wilsher M.Use of the 'CURB 65' score in hospital practice[J]. Intern Med J,2010,40(12):828-832. [11] Ronan D, Nathwani D, Davey P, et al.Predicting mortality in patients with community-acquired pneumonia and low CURB-65 scores[J]. Eur J Clin Microbiol Infect Dis,2010,29(9):1117-1124. [12] Dwyer R, Hedlund J, Darenberg J, et al.Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia[J]. Scand J Infect Dis,2011,43(6-7):448-455. [13] Guo Q, Li HY, Zhou YP, et al.Weight of the CURB-65 criteria for community-acquired pneumonia in a very low-mortality-rate setting[J]. Intern Med,2012,51(18):2521-2527. [14] Nüllmann H, Pflug MA, Wesemann T, et al.External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia[J]. BMC Infect Dis,2014,14:39. [15] Aujesky D, Auble TE, Yealy DM, et al.Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia[J]. Am J Med,2005, 118(4):384-392. [16] Challen K, Bright J, Bentley A, et al.Physiological-social score (PMEWS) [17] Ananda-Rajah MR, Charles PG, Melvani S, et al.Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia[J]. Scand J Infect Dis,2008,40(4):293-300. [18] Charles PG, Wolfe R, Whitby M, et al.SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia[J]. Clin Infect Dis,2008,47(3):375-384. [19] Shindo Y, Sato S, Maruyama E, et al.Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia[J]. Respirology,2008,13(5):731-735. [20] Claessens YE, Mathevon T, Kierzek G, et al.Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia[J]. Intensive Care Med,2010,36(5):799-809. [21] España PP, Capelastegui A, Quintana JM, et al.Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia[J]. J Infect,2010,60(2):106-113. [22] Abisheganaden J, Ding YY, Chong WF, et al.Predicting mortality among older adults hospitalized for community-acquired pneumonia: an enhanced confusion, urea, respiratory rate and blood pressure score compared with pneumonia severity index[J]. Respirology,2012,17(6):969-975. [23] Luque S, Gea J, Saballs P, et al.Prospective comparison of severity scores for predicting mortality in community-acquired pneumonia[J]. Rev Esp Quimioter,2012,25(2):147-154. [24] Kim HI, Kim SW, Chang HH, et al.Mortality of community-acquired pneumonia in Korea: assessed with the pneumonia severity index and the CURB-65 score[J]. J Korean Med Sci,2013,28(9):1276-1282. [25] Mbata GC, Chukwuka CJ, Onyedum CC, et al.The CURB-65 scoring system in severity assessment of Eas-tern Nigerian patients with community-acquired pneumonia: a prospective observational study[J]. Prim Care Respir J,2013,22(2):175-180. [26] Alavi-Moghaddam M, Bakhshi H, Rezaei B, et al.Pneumonia severity index compared to CURB-65 in predicting the outcome of community acquired pneumonia among patients referred to an Iranian emergency department: a prospective survey[J]. Braz J Infect Dis,2013,17(2):179-183. [27] Ribeiro C, Ladeira I, Gaio AR, et al.Pneumococcal pneumonia-Are the new severity scores more accurate in predicting adverse outcomes?[J]. Rev Port Pneumol,2013, 19(6):252-259. [28] Varshochi M, Kianmehr P, Naghavi-Behzad M, et al.Correspondence between hospital admission and the pneumonia severity index(PSI), CURB-65 criteria and comparison of their predictive value in mortality and hospital stay[J]. Infez Med,2013,21(2):103-110. [29] Yin Q, Liu B, Chen Y, et al.Soluble thrombomodulin to evaluate the severity and outcome of community-acquired pneumonia[J]. Inflammation 2014,37(4):1271-1279. [30] van der Eerden MM, de Graaff CS, Bronsveld W, et al. Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia[J]. Respir Med,2004,98(9):872-878. [31] Mortensen EM, Restrepo MI, Anzueto A, et al.The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia[J]. Respir Res,2005,6:82. [32] Ortega L, Sierra M, Domínguez J, et al.Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia[J]. Scand J Infect Dis,2005,37(9):657-663. [33] Buising KL, Thursky KA, Black JF, et al.A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia[J]. Thorax,2006,61(5):419-424. [34] Naito T, Suda T, Yasuda K, et al.A validation and potential modification of the pneumonia severity index in elderly patients with community-acquired pneumonia[J]. J Am Geriatr Soc,2006,54:1212-1219. [35] Renaud B, Coma E, Hayon J, et al.Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study[J]. Clin Microbiol Infect,2007,13(9):923-931. [36] Huang DT, Weissfeld LA, Kellum JA, et al.Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia[J]. Ann Emerg Med,2008,52(1):48-58. [37] Johnstone J, Eurich DT, Majumdar SR, et al.Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study[J]. Medicine (Baltimore),2008,87(6):329-334. [38] Chen CZ, Fan PS, Lin CC, et al.Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community-acquired pneumonia[J]. J Formos Med Assoc,2009,108(3):219-223. [39] Robins-Browne KL, Cheng AC, Thomas KA, et al.The SMART-COP score performs well for pneumonia risk stratification in Australia's Tropical Northern Territory: a prospective cohort study[J]. Trop Med Int Health,2012, 17(7):914-919 [40] Suberviola B, Castellanos-Ortega A, Llorca J, et al.Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia[J]. Swiss Med Wkly,2012,142:w13542. [41] Kohno S, Seki M, Takehara K, et al.Prediction of requirement for mechanical ventilation in community-acquired pneumonia with acute respiratory failure: a multicenter prospective study[J]. Respiration,2013,85(1):27-35. [42] Fernandez-Botran R, Uriarte SM, Arnold FW, et al.Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia[J]. Inflammation,2014, 37(4):1158-1166. [43] Davis JS, Cross GB, Charles PG, et al.Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply?[J]. Med J Aust,2010,192(3):133-136. [44] Phua J, See KC, Chan YH, et al.Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia[J]. Thorax,2009,64(7):598-603. [45] Park SY, Park S, Lee MG, et al.Minor criteria of Infectious Disease Society Of America/American Thoracic Society for severe community-acquired pneumonia can predict delayed treatment response[J]. J Korean Med Sci,2012,27(8):907-913. [46] Garau J, Baquero F, Pérez-Trallero E, et al.Factors impacting on length of stay and mortality of community-acquired pneumonia[J]. Clin Microbiol Infect,2008,14(4):322-329. [47] Chalmers JD, Singanayagam A, Akram AR, et al.Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis[J]. Thorax,2010,65(10):878-883. [48] Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study[J]. Thorax,2003,58(5):377-382. [49] Serisier DJ, Williams S, Bowler SD.Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia[J]. Respirology,2013,18(2):291-296. [50] Eccles S, Pincus C, Higgins B, et al.Diagnosis and mana-gement of community and hospital acquired pneumonia in adults: summary of NICE guidance[J]. BMJ,2014,349:g6722. [51] 余跃天, 朱琤, 毛恩强, 等. 阿托伐他丁对缺血性脑卒中患者医院获得性肺炎的影响[J]. 诊断学理论与实践,2015,14(2):169-174. [52] Singanayagam A, Chalmers JD, Hill AT.Severity assessment in community-acquired pneumonia: a review[J]. QJM,2009,102(6):379-388. [53] Marti C, Garin N, Grosgurin O, et al.Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis[J]. Crit Care,2012,16(4):R141. [54] Riquelme R, Jiménez P, Videla AJ, et al.Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia[J]. Int J Tuberc Lung Dis,2011,15(4):542-546. [55] Bjarnason A, Thorleifsdottir G, Löve A, et al.Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, po-pulation-based study[J]. PLoS One,2012,7(10):e46816. [56] Myles PR, Nguyen-van-Tam JS, Lim WS, et al. Comparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective data[J]. PLoS One,2012,7(4):e34428. [57] Muller MP, McGeer AJ, Hassan K, et al. Evaluation of pneumonia severity and acute physiology scores to predict ICU admission and mortality in patients hospitalized for influenza[J]. PLoS One,2010,5(3):e9563. [58] 尹玉东, 曹彬. 社区获得性肺炎诊治指南解读: 从病情严重度分层角度[J]. 中国循证医学杂志,2015,15(7):756-760. |
[1] | 包志瑶, 孟文凯, 沈继敏, 李庆云. 成人继发于化脓性扁桃体炎的血行播散性肺炎1例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(04): 520-523. |
[2] | 冯一梅, 陈小丽, 张曦. 国内诊断学PBL教学法对临床医学生学习效果影响的荟萃分析[J]. 诊断学理论与实践, 2019, 18(05): 595-601. |
[3] | 周妍, 顾祎. 血清维生素D水平与老年人社区获得性肺炎严重程度的相关性研究[J]. 诊断学理论与实践, 2017, 16(06): 612-616. |
[4] | 王琳琳, 祝程诚, 张庆五, 陈婷, 吴舜. 血清PCT、IL-6、CRP水平在老年社区获得性肺炎鉴别诊断中的价值[J]. 诊断学理论与实践, 2017, 16(05): 532-536. |
[5] | 杨菁, 包扬, 庞小芬, 聂子淮, 崔羽. 有氧运动对类风湿关节炎患者自评健康状况影响的荟萃分析[J]. 诊断学理论与实践, 2017, 16(03): 328-332. |
[6] | 王晋, 王松涛, 刘晓杨, 洪勇智, 赵鹏. 脂肪酸的摄入与子宫内膜癌相关性的荟萃分析[J]. 诊断学理论与实践, 2016, 15(06): 595-601. |
[7] | 李媛媛, 张舒, 曹波, 陆晓晔, 刘黎, 陈杰, 归茜, 徐欣晖, 吕利雄, 朱长清,. 几种感染性疾病中外周血T淋巴细胞亚群变化的检测及其临床意义研究[J]. 诊断学理论与实践, 2015, 14(04): 363-366. |
[8] | 郭海英, 包婺平, 周新,. 隐源性机化性肺炎误诊社区获得性肺炎24例并文献复习[J]. 诊断学理论与实践, 2013, 12(02): 166-169. |
[9] | 区满春, 曾敏怡, 石任任, 陈靖, 方劭桦, 谢玮, 冯莹,. 静脉血栓栓塞症高危因素和临床表现的荟萃分析[J]. 诊断学理论与实践, 2011, 10(02): 113-116. |
[10] | 刘扬, 魏殿军, 马全玲,. 革兰染色痰涂片镜检与痰培养的荟萃分析[J]. 诊断学理论与实践, 2007, 6(02): 152-154. |
[11] | 邓伟吾. 重视呼吸系统疾病的临床循证诊断[J]. 诊断学理论与实践, 2003, 2(01): 5-6. |
阅读次数 | ||||||||||||||||||||||||||||||||||||||||||||||||||
全文 132
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
摘要 265
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||